Antiemetics for Cancer Treatment

GUIDELINES Pocketcards are multifold pocketcards containing society-endorsed, evidence-based treatment guidelines in a brief algorithmic format that is most preferred by practicing clinicians, quality managers, nurses, educators, and medical students. The Antiemetics for Cancer Treatment GUIDELINES Pocketcard is endorsed by the American Society of Clinical Oncology (ASCO) and reflects the latest guideline update. It contains risk assessment for both chemotherapy- and radiation-induced nausea and vomiting, a detailed list of available agents and dosing recommendations, a treatment algorithm, and a brief description of the guideline methodology. The Antiemetics for Cancer Treatment GUIDELINES Pocketcard provides all that is needed to make accurate clinical decisions at the point of care including key points; risk categories for chemotherapeutic agents; risk by site of radiation therapy; treatment algorithm; detailed treatment recommendations for peds, combination and multi-day therapy, stem cell or bone marrow transplant; current medication tables; and detailed drug information including strengths, formulations, and comments. Applications include point-of-care, education, QI interventions, clinical trials, medical reference, and clinical research.